Pediatric Old World cutaneous leishmaniasis treated with oral fluconazole: A case series
- 26 March 2018
- journal article
- research article
- Published by Wiley in Pediatric Dermatology
- Vol. 35 (3) , 384-387
Abstract
Background: Cutaneous leishmaniasis has an incidence of 0.7–1.2 million cases per year and represents a growing concern in the outpatient dermatologic practice in Europe because of imported cases due to increased travel to risk areas and to immigration phenomena. When dealing with children, the treatment can be challenging because of side effects and pain of classic antimonial therapy leading to poor rates of course completion and requirement of sedation for several children.Methods: We retrospectively studied three cases of cutaneous leishmaniasis in pediatric patients, between the ages of 3 and 6 years of age, treated with oral fluconazole. We examined the efficacy, the tolerability, the safety profile and the cosmetic result of fluconazole at a dose of 6 mg/kg/daily for 6 weeks.Results: The patients had a complete resolution of their lesions with minimal scarring. No adverse effect was reported. The leishmaniasis species identified were L. major or L. tropica.Conclusion: Considering sides effects and the parents’ and the clinician's concern for systemic treatment in the pediatric population, fluconazole represents a valid, safe and easily manageable option for Old World cutaneous leishmaniasis in pediatric outpatients caused by L. major or L. tropica.Keywords
This publication has 14 references indexed in Scilit:
- Leishmaniasis: a reviewF1000Research, 2017
- Chronic amastigote‐negative cutaneous leishmaniasis: A clinical, histopathologic and molecular study of 27 cases with emphasis on atypical and pseudolymphomatous presentationsJournal of Cutaneous Pathology, 2017
- Cutaneous and mucocutaneous leishmaniasisJournal of the American Academy of Dermatology, 2015
- Can a simple outpatient-based treatment be used to treat cutaneous leishmaniasis in young children? A Critically Appraised TopicBritish Journal of Dermatology, 2014
- High-Dose Oral Fluconazole Therapy Effective for Cutaneous Leishmaniasis Due to Leishmania (Vianna) braziliensisClinical Infectious Diseases, 2011
- Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: A randomized clinical trialJournal of the American Academy of Dermatology, 2011
- Cutaneous leishmaniasisThe Lancet Infectious Diseases, 2007
- Cutaneous Leishmaniasis: Three Children with Leishmania major Successfully Treated with ItraconazolePediatric Dermatology, 2006
- Cutaneous Leishmaniasis Caused by Leishmania tropica: Treatment with Oral FluconazoleDermatology, 2005
- Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control studyJournal of the American Academy of Dermatology, 1992